Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Complications

Cardiac systolic function before and after hematopoietic stem cell transplantation

Abstract

In order to examine the effect of hematopoietic stem cell transplantation (HSCT) on cardiac systolic function, we measured left ventricular ejection fraction (LVEF) by radioventriculography (RVG) before and after the transplantation procedure. One hundred and forty-eight patients were examined, 96 undergoing allogeneic grafting and 52 autologous. Fifty patients had CML, 48 AML, 21 ALL, 18 multiple myeloma and 11 breast cancer. The second RVG examination was performed 22 to 227 days (median 60 days) after HSCT. The mean LVEF value in the whole patient group was 60.2% (range 39–81%) before and 61.1% (35–86%) after transplantation. Patients with CML had significantly higher LVEF before transplantation than patients with acute leukemia (P = 0.007) and multiple myeloma (P = 0.005). No significant changes in mean LVEF between the pre- and post-transplant measurements were seen in any of the diagnostic subgroups or in allogeneic or autologous recipients. None of the 148 patients in the study has shown any signs of clinical heart failure at 2, 5 to 10 years follow-up. Patients who had received anthracyclines in the previous treatment had significantly lower LVEF before transplantation but showed no increased risk of decline in cardiac function. In conclusion, the HSCT procedure does not seem to affect myocardial function 1–7 months after transplantation. Bone Marrow Transplantation (2000) 26, 187–192.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Cazin B, Gorin NC, Laporte JP et al. Cardiac complications after bone marrow transplantation. A report on a series of 63 consecutive transplantations Cancer 1986 57: 2061–2069

    Article  CAS  Google Scholar 

  2. Hertenstein B, Stefanic M, Schmeiser T et al. Cardiac toxicity of bone marrrow transplantation: predictive value of cardiologic evaluation before transplant J Clin Oncol 1994 12: 998–1004

    Article  CAS  Google Scholar 

  3. Kupari M, Volin L, Suokas A et al. Cardiac involvement in bone marrow transplantation: serial changes J Intern Med 1990 227: 259–266

    Article  CAS  Google Scholar 

  4. Bernuth G, Adam D, Hofstetter R et al. Cyclophosphamide cardiotoxicity Eur J Ped 1980 134: 87–90

    Article  Google Scholar 

  5. Goldberg MA, Antin JH, Guinan EC et al. Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk Blood 1986 68: 1114–1118

    CAS  PubMed  Google Scholar 

  6. Gottdiener JS, Appelbaum FR, Ferrans VJ et al. Cardiotoxicity associated with high-dose cyclophosphamide therapy Arch Intern Med 1981 141: 758–763

    Article  CAS  Google Scholar 

  7. Mills BA, Roberts RW . Cyclophosphamide-induced cardiomyopathy Cancer 1979 43: 2223–2226

    Article  CAS  Google Scholar 

  8. Steinhertz LJ, Steinhertz PG, Mangiacasale D et al. Cardiac changes with cyclophosphamide Med Ped Oncol 1981 9: 417–422

    Article  Google Scholar 

  9. von Hoff DD, Rozencweig M, Piccart M . The cardiotoxicity of anticancer agents Semin Oncol 1982 39: 23–33

    Google Scholar 

  10. Ali MK, Kahlil KG, Fuller LM et al. Radiation-related myocardial injury. Management of two cases Cancer 1976 38: 1941–1946

    Article  CAS  Google Scholar 

  11. Cohn KE, Stewart JR, Fajardo LF et al. Heart disease following radiation Medicine 1967 46: 281–298

    Article  CAS  Google Scholar 

  12. Fajardo LF, Stewart JR, Cohn KE . Morphology of radiation-induced heart disease Arch Pathol 1968 86: 512–519

    CAS  PubMed  Google Scholar 

  13. Muggia FM, Cassileth PA . Constrictive pericarditis following radiation therapy Am J Med 1968 44: 116–123

    Article  CAS  Google Scholar 

  14. von Hoff DD, Layard MW, Basa P et al. Risk factors for doxorubicine induced congestive heart failure Ann Intern Med 1979 91: 710–717

    Article  CAS  Google Scholar 

  15. Stewart JR, Fajardo LF . Radiation-induced heart disease: an update Prog Cardio Dis 1984 17: 173–194

    Article  Google Scholar 

  16. Buja LM, Ferrans VJ, Graw RG Jr . Cardiac pathologic findings in patients treated with bone marrow Hum Pathol 1976 7: 17–45

    Article  CAS  Google Scholar 

  17. Doroshow JH . Doxorubicin-induced cardiac damage New Engl J Med 1991 324: 843–845

    Article  CAS  Google Scholar 

  18. Lenaz L, Page JA . Cardiotoxicity of doxorubicine and related anthracyclines Cancer Treat Rev 1976 3: 111–120

    Article  CAS  Google Scholar 

  19. von Hoff D, Rosencweig M, Layard M et al. Daunorubicin-induced cardiotoxicity in children and adults Am J Med 1977 62: 200–208

    Article  CAS  Google Scholar 

  20. Schwartz GR, McKenzie WB, Alexander J et al. Congestive heart failure and left ventricular ejection fraction complicating doxorubicin therapy Am J Med 1987 82: 1109–1118

    Article  CAS  Google Scholar 

  21. Ljungman P, Björkstrand B, Garthon G et al. High-dose chemotherapy in breast cancer. Promising results in combination with stem cell support (in Swedish) Läkartidningen 1995 92: 851–853

    Google Scholar 

  22. Antman K, Ayash L, Elias A et al. High-dose cyclophosphamide, thiotepa and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard dose therapy: analysis by age J Natl Cancer Inst 1994 16: 91–94

    Google Scholar 

  23. Björkstrand B, Ljungman P, Bird JM et al. Double high-dose chemoradiotherapy with autologous stem cell transplantation can induce molecular remission in multiple myeloma Bone Marrow Transplant 1995 15: 367–371

    PubMed  Google Scholar 

  24. Praga C, Beretta G, Vigo PL et al. Adriamycin cardiotoxicity: a survey of 1273 patients Cancer Treat Rep 1979 63: 827–834

    CAS  PubMed  Google Scholar 

  25. Hollingshead LM . Idarubicin: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the chemotherapy of cancer Drugs 1991 42: 690–718

    Article  CAS  Google Scholar 

  26. Neri B, Ciui-Neri C, Bandinelli H et al. Doxorubicin and epirubicin cardiotoxicity: experimental and clinical aspects Int J Clin Pharmacol Ther Tox 1989 27: 217–221

    CAS  Google Scholar 

  27. Alexander J, Dainiak N, Berger HJ et al. Serial assessment of doxorubicin cardio toxicity with quantitative radionuclide angiocardiography New Engl J Med 1979 300: 278–283

    Article  CAS  Google Scholar 

  28. Schwartz RG, McKenzie WB, Alexander J et al. Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy. Seven-year experience using serial radionuclide angiocardiography Am J Med 1987 82: 1109–1118

    Article  CAS  Google Scholar 

  29. Kupari M, Volin L, Suokas A et al. Cardiac involvement in bone marrow transplantation Bone Marrow Transplant 1990 5: 91–98

    CAS  PubMed  Google Scholar 

  30. Carlsson K, Smedmyr B, Bäcklund L et al. Subclinical disturbances in cardiac function at rest and in gas exchange during exercise are common findings after autologous bone marrow transplantation Bone Marrow Transplant 1994 14: 949–954

    Google Scholar 

  31. Burow RD, Strauss HW, Singleton R et al. Analysis of left ventricular function from multiple gated acquisition cardiac blood pool imaging. Comparison to contrast angiography Circulation 1977 56: 1024–1028

    Article  CAS  Google Scholar 

  32. Folland ED, Hamilton GW, Larson SM et al. The radionuclide ejection fraction: a comparison of three radionuclide techniques with contrast angiography J Nucleic Med 1977 18: 1159–1166

    CAS  Google Scholar 

  33. Marshall RC, Berger HJ, Reduto LA et al. Variability in sequential measures of left ventricular performance assessed with radionuclide angiocardiography Am J Cardiol 1978 41: 531–536

    Article  CAS  Google Scholar 

  34. Wackers FJ, Berger HJ, Johnstone DE et al. Multiple gated cardiac blood pool imaging for left ventricular ejection fraction: validation of the technique and assessment of variability Am J Cardiol 1979 43: 1159–1166

    Article  CAS  Google Scholar 

  35. Marshall RC, Berger HJ, Costin JC et al. Assessment of cardiac performance with quantitative radionuclide angiocardiography: sequential left ventricular ejection fraction, normalized left ventricular ejection rate, and regional wall motion Circulation 1977 56: 820–829

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lehmann, S., Isberg, B., Ljungman, P. et al. Cardiac systolic function before and after hematopoietic stem cell transplantation. Bone Marrow Transplant 26, 187–192 (2000). https://doi.org/10.1038/sj.bmt.1702466

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702466

Keywords

This article is cited by

Search

Quick links